Abstract
A series of structurally novel small molecule inhibitors of human α-thrombin was prepared to elucidate their structure–activity relationships (SARs), selectivity and activity in vivo. BMS-189664 ( 3) is identified as a potent, selective, and orally active reversible inhibitor of human α-thrombin which is efficacious in vivo in a mouse lethality model, and at inhibiting both arterial and venous thrombosis in cynomolgus monkey models.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have